Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

The infectious BAC genomic DNA expression library: a high capacity vector system for functional genomics.

Lufino MM, Edser PA, Quail MA, Rice S, Adams DJ, Wade-Martins R.

Sci Rep. 2016 Jun 29;6:28644. doi: 10.1038/srep28644.

2.

Lipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson's Disease.

Chen W, Li H, Liu Z, Yuan W.

Front Aging Neurosci. 2016 Apr 5;8:68. doi: 10.3389/fnagi.2016.00068. eCollection 2016. Review.

3.

Molecular-genetic imaging of cancer.

Minn I, Menezes ME, Sarkar S, Yarlagadda K, Das SK, Emdad L, Sarkar D, Fisher PB, Pomper MG.

Adv Cancer Res. 2014;124:131-69. doi: 10.1016/B978-0-12-411638-2.00004-5. Review.

4.

Expanding the clinical indications for α(1)-antitrypsin therapy.

Lewis EC.

Mol Med. 2012 Sep 7;18:957-70. doi: 10.2119/molmed.2011.00196. Review.

5.

α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection.

Shahaf G, Moser H, Ozeri E, Mizrahi M, Abecassis A, Lewis EC.

Mol Med. 2011 Sep-Oct;17(9-10):1000-11. doi: 10.2119/molmed.2011.00145. Epub 2011 Jun 9.

6.

Hydrodynamic gene delivery and its applications in pharmaceutical research.

Bonamassa B, Hai L, Liu D.

Pharm Res. 2011 Apr;28(4):694-701. doi: 10.1007/s11095-010-0338-9. Epub 2010 Dec 30. Review.

7.

Delivery of an EBV episome by a self-circularizing helper-dependent adenovirus: long-term transgene expression in immunocompetent mice.

Gil JS, Gallaher SD, Berk AJ.

Gene Ther. 2010 Oct;17(10):1288-93. doi: 10.1038/gt.2010.75. Epub 2010 May 13.

8.

Self-assembled lipid nanomedicines for siRNA tumor targeting.

Tseng YC, Huang L.

J Biomed Nanotechnol. 2009 Aug;5(4):351-63. Review.

9.

Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs.

Hibbitt OC, McNeil E, Lufino MM, Seymour L, Channon K, Wade-Martins R.

Mol Ther. 2010 Feb;18(2):317-26. doi: 10.1038/mt.2009.249. Epub 2009 Oct 27.

10.

Lipid-based systemic delivery of siRNA.

Tseng YC, Mozumdar S, Huang L.

Adv Drug Deliv Rev. 2009 Jul 25;61(9):721-31. doi: 10.1016/j.addr.2009.03.003. Epub 2009 Mar 26. Review.

11.

Robust in vivo transduction of a genetically stable Epstein-Barr virus episome to hepatocytes in mice by a hybrid viral vector.

Gallaher SD, Gil JS, Dorigo O, Berk AJ.

J Virol. 2009 Apr;83(7):3249-57. doi: 10.1128/JVI.01721-08. Epub 2009 Jan 21.

12.

Nonviral gene delivery: what we know and what is next.

Gao X, Kim KS, Liu D.

AAPS J. 2007 Mar 23;9(1):E92-104. Review.

13.

Insulin expression in livers of diabetic mice mediated by hydrodynamics-based administration.

He CX, Shi D, Wu WJ, Ding YF, Feng DM, Lu B, Chen HM, Yao JH, Shen Q, Lu DR, Xue JL.

World J Gastroenterol. 2004 Feb 15;10(4):567-72.

14.

Generating and manipulating transgenic animals using transposable elements.

Largaespada DA.

Reprod Biol Endocrinol. 2003 Nov 7;1:80. Review.

15.

Environmental, occupational, and genetic risk factors for alpha-1 antitrypsin deficiency.

Sharp RR, de Serres F, Newman L, Sandhaus RA, Walsh JW, Hood E, Harry GJ.

Environ Health Perspect. 2003 Nov;111(14):1749-52.

16.

EBNA-1, a bifunctional transcriptional activator.

Kennedy G, Sugden B.

Mol Cell Biol. 2003 Oct;23(19):6901-8.

17.

Retrofitting BACs with G418 resistance, luciferase, and oriP and EBNA-1 - new vectors for in vitro and in vivo delivery.

Magin-Lachmann C, Kotzamanis G, D'Aiuto L, Wagner E, Huxley C.

BMC Biotechnol. 2003 Feb 3;3(1):2.

Supplemental Content

Support Center